Fig. 1.
Low-dose Ara-C (LODAC) increases Hb levels but not CD11b expression in HL-60/Bcr-Abl cells.
Following treatment with 10 nmol/L Ara-C for 7 days, Hb levels (A) or CD11b expression (B) was determined in HL-60/Bcr-Abl and K562 cells.
Low-dose Ara-C (LODAC) increases Hb levels but not CD11b expression in HL-60/Bcr-Abl cells.
Following treatment with 10 nmol/L Ara-C for 7 days, Hb levels (A) or CD11b expression (B) was determined in HL-60/Bcr-Abl and K562 cells.
